Baytril Otic 10 mg (Silver Sulfadiazine EMULSION) 10 MG

BAYTRIL OTIC 10 MG is a topical emulsion containing silver sulfadiazine, designed for otic (ear) use. It is commonly used for managing ear infections and promoting healing in the ear canal.

Strength

10 MG

Manufacturer / TM Owner

ELANCO CANADA LIMITED

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

BAYTRIL OTIC 10 MG is primarily used for treating ear infections and promoting healing in the ear canal. This medication is often recommended for conditions that require antimicrobial and anti-inflammatory support in the ear. It is formulated to provide localized treatment, making it suitable for managing ear-related issues.

Side Effects

When applied to the ear, BAYTRIL OTIC 10 MG may help reduce inflammation and fight infection. Users often report relief from discomfort and improved healing in the treated area. As with any medication, individual responses may vary.

Precautions & Warnings

Before using BAYTRIL OTIC 10 MG, it is important to consult with a healthcare professional, especially if you have a history of allergies or sensitivities to silver sulfadiazine. Avoid contact with eyes and other mucous membranes. Follow the instructions provided by your healthcare provider for safe and effective use.

Avoid Interactions

BAYTRIL OTIC 10 MG may interact with other medications or substances. It is advisable to inform your healthcare provider about any other medications you are taking, including over-the-counter drugs and supplements. Always follow the guidance of a healthcare professional to minimize potential interactions.

Frequently Asked Questions

BAYTRIL OTIC 10 MG is used for treating ear infections and promoting healing in the ear canal.

BAYTRIL OTIC 10 MG should be applied to the ear as directed by a healthcare professional. Follow the instructions provided with the medication.

Common effects may include reduced inflammation and relief from ear discomfort. Individual responses can vary.

It is important to consult a healthcare provider before using BAYTRIL OTIC 10 MG with other medications to avoid potential interactions.

BAYTRIL OTIC 10 MG should be used under the guidance of a healthcare professional, especially for individuals with allergies or sensitivities.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.